載入...
Molecular diagnostics of lung cancer in the clinic
According to current practice guidelines, all patients with advanced non-small cell lung cancer (NSCLC) should undergo predictive biomarker testing. For squamous cell carcinoma patients, PD-L1 immunohistochemistry is indicated to select patients for immunotherapy in the first line. For lung adenocar...
Na minha lista:
| 發表在: | Transl Lung Cancer Res |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653520/ https://ncbi.nlm.nih.gov/pubmed/29114472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.08.03 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|